CClinicalTrials.gg
CompletedNCT00298974Updated Jan 25, 2011

A Study of Pain Relief in Osteoarthritis

A Phase 3 interventional study of hydrocodone / acetaminophen extended release and Placebo in Osteoarthritis, sponsored by Abbott. Completed at 83 sites in United States. Open to participants aged 21 Years to 80 Years. Per ClinicalTrials.gov, last updated 2011-01-25.

Sponsored by Abbott · Phase 3, Interventional, and Treatment

Phase
Phase 3
Study type
Interventional
Enrollment
873
Allocation
Randomized
Ages
21 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to compare the safety and pain-relieving ability of Vicodin CR to placebo in subjects with osteoarthritis (OA) of the hip or knee.

02

Conditions studied

  • Osteoarthritis

Browse trials for

Keywords

  • Osteoarthritis of the hip or knee
03

In context

Osteoarthritis

4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's enrollment of 873 is above the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

Abbott is the lead sponsor of 350 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Males and females ages 21 to 80
  • If female, must be of non-child bearing potential or practicing birth control
  • Has osteoarthritis of the hip or knee
  • Requires therapeutic doses of medication for osteoarthritis pain
  • Has sufficient pain to justify the use of around-the-clock opioids

Exclusion criteria

Exclusion Criteria:

  • Is associated with any currently ongoing research study, or has previously participated in a Vicodin CR study
  • Is allergic to or has had a serious reaction to hydrocodone, other opioids, or acetaminophen
  • Cannot discontinue pain medications, even for the short time prior to the study start
  • Has any clinically significant illness or recent injury, or has any significant laboratory abnormality, or has recently had major surgery
  • Has a history of gastric bypass surgery or preexisting severe gastrointestinal narrowing, or history of diseases that may narrow the gastrointestinal tract
  • Has a history of malnutrition or starvation
  • Has a history of drug (licit or illicit) or alcohol abuse or addiction, or consumes more than 4 alcoholic drinks per day
  • Has a history of a major depressive episode within the past 2 years, or requires treatment with certain drugs for depression, or has a history of major psychiatric disorder
  • Pregnant or breastfeeding females
  • Is incapacitated, bedridden or confined to a wheelchair
  • Has initiated any new therapy or medication for OA within 1 month of screening
  • Has had surgery, certain types of procedures, or received certain medications for osteoarthritis within a specified time frame
  • Has other conditions that may cause pain, such as rheumatoid arthritis or gout
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double
Enrollment
873 participants (actual)

Study arms

  • Experimental
    hydrocodone/acetaminophen extended release

    Drug: hydrocodone / acetaminophen extended release

  • Placebo comparator
    Placebo

    Drug: Placebo

Interventions

  • Drughydrocodone / acetaminophen extended release

    2 tablets twice daily

    Also known as: ABT-712

  • DrugPlacebo

    2 tablets twice daily

06

What researchers measure

Primary outcomes

  1. Pain Intensity

    Arthritis Pain Intensity measured by a 100mm Visual Analog Scale (VAS)

    Time frame: 12 weeks

Secondary outcomes

  1. Pain intensity difference (PID) from baseline to each scheduled evaluation

    Time frame: 12 weeks

  2. Western Ontario and McMaster (WOMAC) Osteoarthritis Index total score

    Time frame: 12 weeks

  3. SF-36v2 Health Status Survey

    Time frame: 12 weeks

07

Study locations

83 sites
  • Site Ref # / Investigator 423
    Birmingham, Alabama 35235, United States
  • Site Ref # / Investigator 581
    Birmingham, Alabama 35235, United States
  • Site Ref # / Investigator 459
    Birmingham, Alabama 35244, United States
  • Site Ref # / Investigator 580
    Mobile, Alabama 36608, United States
  • Site Ref # / Investigator 479
    Phoenix, Arizona 85012, United States
  • Site Ref # / Investigator 543
    Phoenix, Arizona 85014, United States
  • Site Ref # / Investigator 2582
    Phoenix, Arizona 85023, United States
  • Site Ref # / Investigator 2421
    Sierra Vista, Arizona 85635, United States
  • Site Ref # / Investigator 453
    Tempe, Arizona 85282, United States
  • Site Ref # / Investigator 584
    Tucson, Arizona 85712, United States
  • Site Ref # / Investigator 393
    Tucson, Arizona 85741, United States
  • Site Ref # / Investigator 526
    Anaheim, California 92801, United States
  • Site Ref # / Investigator 533
    Buena Park, California 90620, United States
  • Site Ref # / Investigator 357
    Fair Oaks, California 95628, United States
  • Site Ref # / Investigator 721
    Los Angeles, California 90095-1670, United States
  • Site Ref # / Investigator 439
    San Diego, California 92108, United States
  • Site Ref # / Investigator 709
    Littleton, Colorado 80120, United States
  • Site Ref # / Investigator 583
    Wheat Ridge, Colorado 80033, United States
  • Site Ref # / Investigator 497
    Clearwater, Florida 33756, United States
  • Site Ref # / Investigator 417
    Daytona Beach, Florida 32117, United States
  • Site Ref # / Investigator 505
    DeLand, Florida 32720, United States
  • Site Ref # / Investigator 366
    Jupiter, Florida 33458-7200, United States
  • Site Ref # / Investigator 388
    Longwood, Florida 32779, United States
  • Site Ref # / Investigator 474
    Miami, Florida 33156, United States
  • Site Ref # / Investigator 433
    Ocala, Florida 34471, United States
  • Site Ref # / Investigator 420
    Ocala, Florida 34474, United States
  • Site Ref # / Investigator 359
    Oldsmar, Florida 34677, United States
  • Site Ref # / Investigator 457
    Pembroke Pines, Florida 33024, United States
  • Site Ref # / Investigator 434
    Plantation, Florida 33324, United States
  • Site Ref # / Investigator 489
    Plantation, Florida 33324, United States
  • Site Ref # / Investigator 719
    Port Orange, Florida 32127, United States
  • Site Ref # / Investigator 481
    St. Petersburg, Florida 33703, United States
  • Site Ref # / Investigator 2594
    Tampa, Florida 33613, United States
  • Site Ref # / Investigator 458
    West Palm Beach, Florida 33409-3509, United States
  • Site Ref # / Investigator 437
    Marietta, Georgia 30066, United States
  • Site Ref # / Investigator 2598
    Meridian, Idaho 83642, United States
  • Site Ref # / Investigator 550
    Chicago, Illinois 60611, United States
  • Site Ref # / Investigator 511
    Evansville, Indiana 47714, United States
  • Site Ref # / Investigator 523
    Newburgh, Indiana 47630, United States
  • Site Ref # / Investigator 355
    Louisville, Kentucky 40213, United States
  • Site Ref # / Investigator 410
    New Orleans, Louisiana 70115, United States
  • Site Ref # / Investigator 468
    Owings Mills, Maryland 21117, United States
  • Site Ref # / Investigator 418
    Pasadena, Maryland 21122, United States
  • Site Ref # / Investigator 560
    Brockton, Massachusetts 02301, United States
  • Site Ref # / Investigator 715
    Fall River, Massachusetts 02720, United States
  • Site Ref # / Investigator 522
    Wellesley Hills, Massachusetts 02481-2106, United States
  • Site Ref # / Investigator 527
    West Yarmouth, Massachusetts 02673, United States
  • Site Ref # / Investigator 529
    Biloxi, Mississippi 39531, United States
  • Site Ref # / Investigator 2544
    Florissant, Missouri 63031, United States
  • Site Ref # / Investigator 2419
    St. Louis, Missouri 63141, United States
  • Site Ref # / Investigator 411
    Omaha, Nebraska 68134, United States
  • Site Ref # / Investigator 389
    Mamaroneck, New York 10543, United States
  • Site Ref # / Investigator 528
    New York, New York 10022, United States
  • Site Ref # / Investigator 501
    Roslyn, New York 11576, United States
  • Site Ref # / Investigator 452
    Monroe, North Carolina 28112, United States
  • Site Ref # / Investigator 349
    Winston-Salem, North Carolina 27103, United States
  • Site Ref # / Investigator 525
    Centerville, Ohio 45459, United States
  • Site Ref # / Investigator 724
    Cincinnati, Ohio 45236, United States
  • Site Ref # / Investigator 521
    Cincinnati, Ohio 45242, United States
  • Site Ref # / Investigator 416
    Cleveland, Ohio 44122, United States
  • Site Ref # / Investigator 582
    Columbus, Ohio 43235, United States
  • Site Ref # / Investigator 530
    Zanesville, Ohio 43701, United States
  • Site Ref # / Investigator 508
    Oklahoma City, Oklahoma 73103, United States
  • Site Ref # / Investigator 723
    Eugene, Oregon 97404, United States
  • Site Ref # / Investigator 2430
    Portland, Oregon 97201, United States
  • Site Ref # / Investigator 493
    Duncansville, Pennsylvania 16635, United States
  • Site Ref # / Investigator 713
    Mechanicsburg, Pennsylvania 17055, United States
  • Site Ref # / Investigator 486
    West Reading, Pennsylvania 19611-1124, United States
  • Site Ref # / Investigator 351
    Cranston, Rhode Island 02920, United States
  • Site Ref # / Investigator 466
    Greenville, South Carolina 29601, United States
  • Site Ref # / Investigator 425
    Greer, South Carolina 29651, United States
  • Site Ref # / Investigator 504
    Milan, Tennessee 38358, United States
  • Site Ref # / Investigator 350
    Austin, Texas 78705, United States
  • Site Ref # / Investigator 558
    Dallas, Texas 75230, United States
  • Site Ref # / Investigator 727
    San Antonio, Texas 78209, United States
  • Site Ref # / Investigator 2420
    San Antonio, Texas 78229, United States
  • Site Ref # / Investigator 476
    San Antonio, Texas 78229, United States
  • Site Ref # / Investigator 450
    Salt Lake City, Utah 84102, United States
  • Site Ref # / Investigator 454
    Chesapeake, Virginia 23320, United States
  • Site Ref # / Investigator 435
    Virginia Beach, Virginia 23451, United States
  • Site Ref # / Investigator 556
    Virginia Beach, Virginia 23454, United States
  • Site Ref # / Investigator 503
    Virginia Beach, Virginia 23455, United States
  • Site Ref # / Investigator 2599
    Spokane, Washington 99204, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 25, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00298974
Lead sponsor
Abbott
First posted
Mar 6, 2006
Start date
Feb 2006
Primary completion
May 2007
Completion
May 2007
Last update
Jan 25, 2011

Study contacts

Rita Jain, M.D.
study director · Abbott

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion